SCHEMBL4618655

SCHEMBL4618655

N#CCNS(=O)(=O)c1cc(S(=O)(=O)c2ccccc2)ccc1Cl

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.56
SLC12A2 P55011 1/20 0.56
SLC12A5 Q9H2X9 1/20 0.56
GLA P06280 1/20 0.54
SFRP1 Q8N474 4/20 0.49
ALDH1A1 P00352 5/20 0.42
POLB P06746 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.40
MAPT P10636 2/20 0.40
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
SLC16A1 P53985 1/20 0.40
CTSS P25774 1/20 0.40
VCAM1 P19320 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4617973 0.87 LMNA (0.53) LMNASLC12A2SLC12A5GLASFRP1
SCHEMBL4616119 0.80 LMNA (0.57) LMNASLC12A2SLC12A5GLASFRP1
SCHEMBL4617968 0.80 LMNA (0.53) LMNASLC12A2SLC12A5GLASFRP1
SCHEMBL4616206 0.79 SFRP1 (0.73) LMNASLC12A2SLC12A5GLASFRP1
SCHEMBL19334397 0.78 SLC22A12 (0.49) LMNASLC12A2SLC12A5GLAALDH1A1
SCHEMBL10389233 0.78 ALDH1A1 (0.55) LMNAALDH1A1SMN1; SMN2L3MBTL1MAPK1
SCHEMBL4618477 0.76 LMNA (0.52) LMNASLC12A2SLC12A5GLASFRP1
SCHEMBL4618233 0.75 LMNA (0.48) LMNASLC12A2SLC12A5GLASFRP1
SCHEMBL4617963 0.74 LMNA (0.47) LMNASLC12A2SLC12A5GLASFRP1
SCHEMBL4616651 0.74 TDP1 (0.66) LMNASLC12A2SLC12A5GLASFRP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 LMNA 4608/4885SLC12A2 1974/4885SLC12A5 1366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.